Korea Investment Corp’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.6M Sell
632,639
-66,664
-10% -$4.44M 0.08% 224
2026
Q1
$43.9M Buy
699,303
+65,344
+10% +$4.55M 0.09% 218
2025
Q4
$42.1M Sell
633,959
-135,705
-18% -$8.77M 0.08% 223
2025
Q3
$51.8M Buy
769,664
+390,501
+103% +$30.9M 0.11% 182
2025
Q2
$33.1M Buy
379,163
+195,180
+106% +$15.3M 0.07% 259
2025
Q1
$12.6M Sell
183,983
-150,900
-45% -$12.3M 0.03% 462
2024
Q4
$26M Buy
334,883
+400
+0.1% +$29.6K 0.06% 296
2024
Q3
$22.4M Sell
334,483
-1,545
-0.5% -$127K 0.05% 316
2024
Q2
$38.1M Sell
336,028
-91,450
-21% -$11.6M 0.1% 199
2024
Q1
$59.3M Buy
427,478
+15,450
+4% +$1.94M 0.15% 142
2023
Q4
$51.1M Sell
412,028
-46,054
-10% -$4.7M 0.13% 166
2023
Q3
$42.7M Sell
458,082
-119,232
-21% -$13.4M 0.13% 180
2023
Q2
$74.2M Buy
577,314
+227,938
+65% +$27.6M 0.21% 115
2023
Q1
$40.6M Buy
349,376
+148,061
+74% +$16.6M 0.12% 201
2022
Q4
$22.8M Sell
201,315
-23,596
-10% -$2.59M 0.07% 278
2022
Q3
$18.1M Buy
224,911
+91,523
+69% +$7.75M 0.06% 317
2022
Q2
$9.94M Buy
133,388
+43,388
+48% +$3.96M 0.03% 420
2022
Q1
$11.5M Sell
90,000
-7,600
-8% -$831K 0.03% 418
2021
Q4
$13.1M Buy
97,600
+27,600
+39% +$3.97M 0.03% 343
2021
Q3
$9.57M Sell
70,000
-9,600
-12% -$1.21M 0.03% 372
2021
Q2
$8.5M Sell
79,600
-400
-0.5% -$38.4K 0.02% 425
2021
Q1
$7.19M Sell
80,000
-30,400
-28% -$2.85M 0.02% 425
2020
Q4
$10.2M Sell
110,400
-143,200
-56% -$12.8M 0.03% 357
2020
Q3
$26.1M Buy
253,600
+36,400
+17% +$3.8M 0.09% 207
2020
Q2
$22M Buy
217,200
+100,400
+86% +$8.98M 0.08% 220
2020
Q1
$7.86M Buy
116,800
+109,600
+1,522% +$6.82M 0.03% 345
2019
Q4
$394K Sell
7,200
-52,800
-88% -$2.5M ﹤0.01% 614
2019
Q3
$2.24M Sell
60,000
-73,200
-55% -$2.84M 0.01% 521
2019
Q2
$4.99M Buy
133,200
+800
+0.6% +$25.1K 0.02% 447
2019
Q1
$3.94M Buy
132,400
+109,200
+471% +$3.84M 0.02% 482
2018
Q4
$695K Buy
+23,200
New +$736K ﹤0.01% 568

Other funds holding DXCM

Korea Investment Corp's DXCM Position: Q2 2026 in Review

Korea Investment Corp reduced its DexCom (DXCM) stake by 9.5% in Q2 2026, selling an estimated $4.44M and leaving 632,639 shares worth $42.6M. The position accounts for 0.08% of the portfolio, ranked #224.

Korea Investment Corp first reported a position in DXCM in Q4 2018 and has held it in 31 quarters since. The position peaked at $74.2M in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Korea Investment Corp held 632,639 shares of DexCom worth $42.6M as of Q2 2026.
  • Korea Investment Corp sold 66,664 DexCom shares in Q2 2026, an estimated $4.44M.
  • DexCom made up 0.08% of Korea Investment Corp's portfolio in Q2 2026, its #224 holding.
  • Korea Investment Corp first reported a position in DexCom in Q4 2018 and has held it in 31 quarters since.
  • Korea Investment Corp's DexCom position peaked at $74.2M in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Korea Investment Corp's 13F filing for Q2 2026, filed 12 Aug 2026.